Threat of ‘life-threatening infections’ causes Florida company to recall ulcer medicine
One lot of Sucralfate Oral Suspension has been recalled because it might be contaminated with bacillus bacteria.
Manufacturer VistaPharm, based in Largo, Florida, a suburb of Tampa, didn’t explain in its recall notice how the ulcer medication got contaminated. But, the risk statement, left no doubt about the seriousness of the problem in its recall alert, which was also posted by the FDA.
“In the population most at risk, the immunocompromised population, there is a reasonable probability that microbial contamination of the oral suspension can result in disseminated, life threatening infections such as endocarditis and necrotizing soft tissue infections,” the alert said.
The lot involved is No. 810300, with an expiration date of Oct. 31, 2023, and went to three wholesale distributors nationwide.
READ MORE: Miami area company recalls sweet corn pancakes as a food allergy danger
People with this drug should reach out to your doctor or pharmacist to discuss a replacement and a refund, if necessary. Questions about this recall should be directed to Inmar, at rxrecalls@Inmar.com or 800-967-5952, Monday through Friday, 9 a.m. to 5 p.m., Eastern time.
Any medical problems you feel are connected to this medicine should be taken to a medical professional first.
After consulting with a medical professional, inform the FDA of any problems connected to the medicine by its MedWatch program. You can do that either by filling out an online reporting form or requesting a reporting form that you can fill out and mail to an address on the form or fax to 800-FDA-0178.
